Are Psychedelic Retreats a Possibility in the US?

In the recent past, psychedelics have moved into mainstream media, which has revealed a lot about the potential benefits various psychedelics such as LSD, MDMA, ketamine and psilocybin possess. In the United States, the state of Oregon became the first state in the country to allow the therapeutic use of psychedelic mushrooms while also decriminalizing psilocybin in the state. Voters in Washington, DC, also approved a ballot measure to decriminalize the use of hallucinogenic mushrooms during the November elections.

While this is progress, the aforementioned psychedelic drugs and other psychedelic substances are still illegal in the country and in many other nations around the world. This is why psychedelic retreats have become so popular, especially in jurisdictions where the substances are not illegal.

One such retreat facility is the MycoMeditations retreat in Jamaica, which was founded in 2015. The center is among the few official psilocybin retreat centers globally and offers psilocybin mushrooms-assisted sessions. The reputed mental health benefits of psychedelics, which include the substance being used as alternative treatments for end-of-life distress and treatment-resistant depression, have seen the center become more popular as many seek more natural remedies for their conditions.

The Jamaican retreat is not the only place where individuals flock to trying to find alternative therapies. Robin Carhart-Harris, the head of the Centre for Psychedelic Research at the Imperial College London, explained that the demand for these therapies exists, explaining that many individuals have contacted him to join clinical trials conducted at the centre. When the centre opened in 2019, it became the first formal site in the world that centered solely on psychedelic research.

In the same year, the Center for Psychedelic and Consciousness Research was opened by Johns Hopkins. Carhart-Harris explained that the individuals who contacted him suffered from various conditions such as addiction, trauma, treatment resistant depression, anorexia, among many others, and appeared desperate and suffering, with no other treatments options to help them manage their conditions.

Research conducted by Carhart-Harris has led him to believe that psychedelics can facilitate life-changing transformations. While retreats may be the up-and-coming thing in the next few years in the United States, what with the expected boom in the psychedelic psilocybin market and the establishment of a wellness retreat in Oregon, it should be acknowledged that without scientific research and findings that led to the discovery of the benefits that various psychedelics possess, retreats would not exist.

Furthermore, as there is still much unknown about psychedelics, individuals looking to try psychedelics in a retreat setting as an alternative therapy should do their own research and find out the repercussions in addition to learning more about the facility to ensure that not only is it safe but has licensed practitioners and counsellors.

A number of companies are poised to benefit from the growing interest in functional mushrooms and psychedelic products. A clear example is Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF), which has moved quickly to leverage its cannabis extracts experience in the development as well as production of medicinal products made from functional mushrooms and psychedelics.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://ibn.fm/PULL

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.